Position Statements

AACU is Against Prior Authorization Policies

AACU Strongly Supports Biomarker Testing

AACU Supports Payer Transparency

Genomic Testing in Prostate Cancer

Advances in the laboratory increasingly provide clinicians with patient-specific genomic information that contributes to individualized risk-stratification, treatment planning, and assessment of hereditary cancer risk (Endorsed by LUGPA)… Read More

AACU Policy Development Process

The AACU is dedicated to developing and advancing heath policy education as it affects urologic practice in order to preserve and promote the professional autonomy of its members and support the highest quality of care for patients.

To do so, the AACU develops evidence-based policy opinions and advocates for these with appropriate bodies, in particular with governments at all levels and private third-party payers. Policy documents are not intended to and should not be treated as legal, medical, or business advice.